Application no. and date | 18852510.9 (espacenet) (Federated) (European Patent Register), 20180904 | Patent/reg. no. and date | DK/EP 3678687, 20220817 | Publication date | 20200715 | Priority no. and date | US 201762553970 P, 20170904 | EP pub. no. and date |
EP 3678687 20200715 | Effective date | | Applicant/owner | 89Bio Ltd., 6 Hamada Street
673340 Herzliya, IL | Applicant ref. no. | 165721 | Inventor | KOPEC, Karla, K., 1223 Trafalgar Lane
West Chester, PA 19080, US, LIU, Patrick, Mengyuan, 12508 Circle Drive
Rockville, MD 20850, US | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 38/18 (2006.01) , A61P 17/00 (2006.01) , A61P 17/02 (2006.01) , A61P 27/02 (2006.01) , A61P 3/10 (2006.01) , A61P 9/10 (2006.01) , C07K 14/50 (2006.01) , C12P 21/00 (2006.01) | Title | MUTANT FGF-21 PEPTIDKONJUGATER OG ANVENDELSER DERAF | Int. application no. | IB2018001112 | Int. publication no. | WO2019043457 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|